Published: 23rd November 2021
SYNLAB UK & Ireland:
SYNLAB sets its Sights on Becoming the UK’s Leading Laboratory Diagnostics Organisation
Published: 23rd August 2023Science for Life, Health and Wellbeing SYNLAB, the medical diagnostics provider, has set out its ambition to become the UK’s leading laboratory…
Modern Slavery & Human Trafficking Statement 2023
Published: 11th July 2023INTRODUCTION This is SYNLAB UK and Ireland’s (SYNLAB UK&I) Modern Slavery and Human Trafficking Statement under Section 54 of the UK Modern…
Exceptional talent honoured during SYNLAB awards programme
Published: 8th December 2022SYNLAB’s 2022 Excellence Awards recognised individuals and teams from across its UK & Ireland services, who display outstanding service in their roles….
SYNLAB Primed to Help Steer NHS’s COVID Bounce Back
Published: 13th October 2022SYNLAB is ready to play a key role in assisting the UK’s ongoing COVID recovery after securing membership of NHS England’s Increasing…
Landmark Day for Pathology Partnership with Launch of Synnovis Brand
Published: 4th October 2022 A pathology partnership performing 32 million tests a year has been relaunched as ‘Synnovis’ – officially heralding the start of a…
Pathology laboratory becomes the first in the UK to support remote plate reading
Published: 15th June 2022A pathology laboratory is leading the way in speeding up access to patient care and treatment after becoming the first in the…
SYNLAB ESG Roadmap and Framework
Published: 17th May 2022Introduction SYNLAB UK&I is thrilled to publish its UK&I ESG Framework and Roadmap, which outlines out how we will achieve our ESG…
GENDER Pay Gap Report 2020-21
Published: 21st September 2021A Message From Our CEO Whilst we are pleased at the improvement in our gender pay gap over the past four years,…
SYNLAB Goes Public
Published: 30th April 2021We are proud to announce that SYNLAB is now listed on the Frankfurt Stock Exchange. This historical milestone is built on the…
